Clinical Trials Directory

Trials / Sponsors / Suzhou Genhouse Bio Co., Ltd.

Suzhou Genhouse Bio Co., Ltd.

Academic / Other · 11 registered clinical trials7 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingA Study to Evaluate Safety, PK and Efficacy of GH55 in Combination With GH21 in Patients With Solid Tumors
Advanced Solid Tumor Cancer
Phase 1 / Phase 22026-02-24
Not Yet RecruitingPhase 2 Clinical Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of GH21 Capsules C
Locally Advanced or Metastatic Solid Tumors
Phase 22025-12-30
Active Not RecruitingA Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of GH2616 in
Advanced Solid Tumor Cancer
Phase 12025-03-27
RecruitingA Phase Ia/Ib Clinical Study of GH56 Capsules in Subjects With MTAP-Deleted Advanced Solid Tumors
Advanced Solid Tumors With MTAP Gene Deletion
Phase 12025-03-07
Not Yet RecruitingGH21 Combined With D-1553 in KRAS G12C Mutant Advanced Solid Tumors
Locally Advanced or Metastatic Solid Tumors Harboring KRAS G12C Mutation
Phase 1 / Phase 22024-07-01
UnknownA Study of GH21 Combined With Previous Target Therapy or Immunotherapy in Patients With Advanced Solid Tumors
Patients With Advanced Solid Tumor, Advanced Solid Tumor With Oncogenic Driver Mutations
Phase 22024-03-22
RecruitingA Phase Ia/Ib Study of GH2616 Tablet in Subjects With Advanced Solid Tumors
Advanced Solid Tumors
Phase 12024-03-20
RecruitingA Phase Ib/II Clinical Study of GH21 Capsules Combined With Osimertinib Mesylate Tablets in Patients With NSCL
Non-Small Cell Lung Cancer With EGFR Mutation
Phase 1 / Phase 22024-03-05
RecruitingGH55 for Advanced Cancers With MAPK Mutations: A Study on Safety and Early Results
Advanced Solid Tumors With MAPK Signal Pathway Mutations
Phase 1 / Phase 22022-12-07
UnknownGH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results
Advanced Solid Tumor, Non-Small Cell Lung Cancer, Pancreatic Cancer
Phase 12022-02-20
Active Not RecruitingGH35 Tablets for Advanced Solid Tumors: A Study on Safety and Early Results
Advanced Solid Tumors Harboring With G12C Mutation
Phase 12021-09-27